Hongxia Liu

10.8k total citations · 2 hit papers
84 papers, 7.6k citations indexed

About

Hongxia Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hongxia Liu has authored 84 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 17 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Hongxia Liu's work include Cancer-related molecular mechanisms research (8 papers), Ubiquitin and proteasome pathways (7 papers) and Autophagy in Disease and Therapy (7 papers). Hongxia Liu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Ubiquitin and proteasome pathways (7 papers) and Autophagy in Disease and Therapy (7 papers). Hongxia Liu collaborates with scholars based in China, United States and Canada. Hongxia Liu's co-authors include Fu‐Sheng Wang, Jinghui Dong, Zhe Xu, Peng Zhao, Jin‐Wen Song, Shuhong Liu, Tingting Gao, Yanhong Tai, Yijin Wang and Jiyuan Zhang and has published in prestigious journals such as PLANT PHYSIOLOGY, International Journal of Molecular Sciences and Hypertension.

In The Last Decade

Hongxia Liu

83 papers receiving 7.4k citations

Hit Papers

Pathological findings of COVID-19 associated with acute r... 2020 2026 2022 2024 2020 2022 2.0k 4.0k 6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pathological findings of COVID-19 associated with acute respiratory distress syndrome
    2020 6.1k citations Hongxia Liu et al. profile →
  2. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma
    2022 216 citations Hongxia Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongxia Liu China 23 4.4k 2.4k 1.4k 883 824 84 7.6k
Yanhong Tai China 22 4.4k 1.0× 2.4k 1.0× 1.2k 0.9× 857 1.0× 1.0k 1.2× 46 7.2k
Peng Xia China 23 4.5k 1.0× 2.4k 1.0× 1.2k 0.8× 689 0.8× 746 0.9× 103 7.6k
Zhe Xu China 24 4.7k 1.0× 2.4k 1.0× 920 0.7× 741 0.8× 969 1.2× 84 7.4k
Jingmin Zhao China 26 4.5k 1.0× 2.4k 1.0× 1.1k 0.8× 651 0.7× 813 1.0× 90 8.0k
Yaxin Wang China 26 5.2k 1.2× 2.8k 1.2× 1.0k 0.7× 1.5k 1.7× 1.4k 1.7× 54 8.7k
Jin‐Wen Song China 17 4.5k 1.0× 2.4k 1.0× 896 0.6× 633 0.7× 749 0.9× 63 6.9k
Yijin Wang China 17 4.5k 1.0× 2.4k 1.0× 760 0.5× 655 0.7× 749 0.9× 52 6.7k
Lin Zhang China 39 2.7k 0.6× 1.9k 0.8× 1.2k 0.9× 842 1.0× 1.9k 2.3× 306 8.3k
Bo Wu China 37 2.8k 0.6× 1.1k 0.4× 1.8k 1.3× 734 0.8× 963 1.2× 173 7.0k
Li Zhu China 16 4.6k 1.0× 2.4k 1.0× 804 0.6× 687 0.8× 778 0.9× 54 7.0k

Countries citing papers authored by Hongxia Liu

Since Specialization
Citations

This map shows the geographic impact of Hongxia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Liu more than expected).

Fields of papers citing papers by Hongxia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Liu. The network helps show where Hongxia Liu may publish in the future.

Co-authorship network of co-authors of Hongxia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Liu. A scholar is included among the top collaborators of Hongxia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Liu. Hongxia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Yan, Xiuli Zhang, Chenyi Wang, et al.. (2024). DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation. Cancer Cell International. 24(1). 382–382. 2 indexed citations
2.
Lin, You‐Yu, Yan Ye, Hongxia Liu, et al.. (2023). SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis. PubMed Central. 7 indexed citations
3.
Li, Hongjing, Xuedong Yin, Hongxia Liu, et al.. (2023). Integrative analysis of renal microRNA and mRNA to identify hub genes and pivotal pathways associated with cyclosporine-induced acute kidney injury in mice. Human & Experimental Toxicology. 42. 3530233739–3530233739. 2 indexed citations
4.
Wang, Junling, Mingsheng Liu, Yudong Fu, et al.. (2023). Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches. Open Life Sciences. 18(1). 20220768–20220768. 1 indexed citations
5.
Liu, Hongxia, Feng Li, You‐Yu Lin, et al.. (2022). Elevated expression of LIF predicts a poor prognosis and promotes cell migration and invasion of clear cell renal cell carcinoma. Frontiers in Oncology. 12. 934128–934128. 5 indexed citations
6.
Ye, Yan, Liangjie Chi, You‐Yu Lin, et al.. (2022). Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer. Frontiers in Pharmacology. 13. 981201–981201. 8 indexed citations
7.
Lv, Yinghua, et al.. (2022). Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD. Therapeutic Advances in Respiratory Disease. 16. 2663645396–2663645396. 10 indexed citations
8.
Cao, Jie, Hongxia Liu, Wenwen Liu, et al.. (2022). Correlation Between Bioelectrical Impedance Analysis and Chest CT-Measured Erector Spinae Muscle Area: A Cross-Sectional Study. Frontiers in Endocrinology. 13. 923200–923200. 6 indexed citations
9.
10.
Liu, Ting, Jiaquan Zhang, Junji Cao, et al.. (2022). Identification of coexistence of biological and non-biological aerosol particles with DAPI (4′,6-diamidino-2-phenylindole) stain. Particuology. 72. 49–57. 9 indexed citations
11.
Wang, Qingshui, Linhong Deng, You‐Yu Lin, et al.. (2021). The Expression and Prognostic Value of SUMO1-Activating Enzyme Subunit 1 and Its Potential Mechanism in Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 729211–729211. 13 indexed citations
12.
Jia, Fengju, Hongxia Liu, & Shan Kang. (2021). NCOA4-Mediated Ferritinophagy: A Vicious Culprit in COVID-19 Pathogenesis?. Frontiers in Molecular Biosciences. 8. 761793–761793. 11 indexed citations
13.
Zhang, Ningyuan, Yunfei Li, Yinghua Lv, et al.. (2019). Quantitative Comparison of the Efficacies of 5 First‐Line Drugs for Primary Restless Leg Syndrome. The Journal of Clinical Pharmacology. 59(9). 1177–1187. 2 indexed citations
14.
15.
16.
Zhou, Liang, Yinghui Wang, Chengshan Ou, et al.. (2015). microRNA-365-targeted nuclear factor I/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma. The International Journal of Biochemistry & Cell Biology. 65. 182–191. 30 indexed citations
17.
Liu, Hongxia, et al.. (2014). Over-expression of p53, p21 and Cdc2 in histologically negative surgical margins is correlated with local recurrence of laryngeal squamous cell carcinoma.. PubMed. 7(7). 4295–302. 15 indexed citations
18.
Qu, Chengkai, Shihua Qi, Li Zhang, et al.. (2013). [Distribution characteristics of organochlorine pesticides in soil from Daiyun Mountain Range in Fujian, China].. PubMed. 34(11). 4427–33. 2 indexed citations
19.
Jin, Yibao, et al.. (2013). Investigation of Pokemon-Regulated Proteins in Hepatocellular Carcinoma Using Mass Spectrometry-Based Multiplex Quantitative Proteomics. European Journal of Mass Spectrometry. 19(2). 111–121. 3 indexed citations
20.
Zhang, Yongping, Yingjian Zhang, Mingwei Wang, et al.. (2011). Fully automated synthesis of 16α-[18F]fluoro-17-βestrogen using Explora GN/LC dual module. 31(3). 196–200. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanhong Tai Breakdown of academic impact, for papers by Peng Xia Breakdown of academic impact, for papers by Zhe Xu Breakdown of academic impact, for papers by Jingmin Zhao Breakdown of academic impact, for papers by Yaxin Wang Breakdown of academic impact, for papers by Jin‐Wen Song Breakdown of academic impact, for papers by Yijin Wang Breakdown of academic impact, for papers by Lin Zhang Breakdown of academic impact, for papers by Bo Wu Breakdown of academic impact, for papers by Li Zhu
Rankless by CCL
2026